Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology

Psychotherapy and Psychosomatics
Andrew A NierenbergClaire A Tilley

Abstract

Systematic biases in decision-making have been well characterized in medical and nonmedical fields but mostly ignored in clinical psychopharmacology. The purpose of this paper is to sensitize clinicians who prescribe psychiatric drugs to the issues of the psychology of risk, especially as they pertain to the risk of side effects. Specifically, the present analysis focuses on heuristic organization and framing effects that create cognitive biases in medical practice. Our purpose is to increase the awareness of how pharmaceutical companies may influence physicians by framing the risk of medication side effects to favor their products.

Citations

Jan 1, 2013·BMC Medical Informatics and Decision Making·Purva AbhyankarPeep Stalmeier
Jul 19, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Elizabeth A Conover, Janine E Polifka
Apr 21, 2011·Health Economics·Dominic HodgkinSue Lee
Aug 12, 2009·CNS Spectrums·Andrew A Nierenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Samuel CoenenPaul Van Royen
© 2022 Meta ULC. All rights reserved